Clover Health Investments, Corp. (CLOV)
- Previous Close
0.6311 - Open
0.6300 - Bid 0.6200 x 600
- Ask 0.6342 x 600
- Day's Range
0.6243 - 0.6302 - 52 Week Range
0.6100 - 1.6300 - Volume
113,675 - Avg. Volume
9,464,320 - Market Cap (intraday)
309.26M - Beta (5Y Monthly) 1.85
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4400 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.44
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
www.cloverhealth.com/en/Recent News: CLOV
Performance Overview: CLOV
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLOV
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLOV
Valuation Measures
Market Cap
312.03M
Enterprise Value
74.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.15
Price/Book (mrq)
1.09
Enterprise Value/Revenue
0.04
Enterprise Value/EBITDA
-0.35
Financial Highlights
Profitability and Income Statement
Profit Margin
-10.48%
Return on Assets (ttm)
-16.98%
Return on Equity (ttm)
-66.33%
Revenue (ttm)
2.04B
Net Income Avi to Common (ttm)
-213.36M
Diluted EPS (ttm)
-0.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
242.68M
Total Debt/Equity (mrq)
1.63%
Levered Free Cash Flow (ttm)
71.6M
Research Analysis: CLOV
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell